sunvozertinib,CLN-081
dizal pharmaceuticals
['sclc', 'sunvozertinib', 'nsclc']
#asco22 overall, much progress in #egfr exon 20 insertion nsclc including data at this meeting on cln-081, sunvozertinib, and osi/neci. great discussion laced with optimism by dr. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him